ARCHIVES

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Study: Women at Higher Risk Of Estrogen Receptor Positive Breast Cancer After Smoking

February 28, 2014

NCAB Wants NCI To Avoid Setting Guidelines Regarding Health Policy

March 4, 1994

In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award

July 10, 1987

ASCO honors physicians for clinical trials participation.

June 4, 2004